Ischemic Myocardial Protection in Transgenic Mice with Cardiac Α1a‐adrenergic Receptor Overexpression

Xin Zhao,Yan Zhang,You-Tang Shen,Lin Yan,Dorothy E. Vatner,Robert M. Graham,Stephen F. Vatner
DOI: https://doi.org/10.1096/fasebj.22.1_supplement.730.31
2008-01-01
Abstract:It is thought that activation of α1A‐adrenergic receptor (α1A‐AR) signaling may be involved in myocardial ischemic preconditioning(IP). If this is correct, then a transgenic (TG) model in which the α1A‐AR is specifically overexpressed only in the heart should be useful for exploring IP mechanisms. To determine if TG mice with cardiac specific overexpression of the α1A ‐AR (66‐fold) exhibited IP, TG mice and their non‐transgenic (NTG) littermates were subjected to left anterior descending coronary artery occlusion for 60 min followed by reperfusion (n=5 in each group). After 24hr, the hearts were perfused and the area at risk determined by Alcian Blue, and infarct area determined by 2, 3, 5‐triphenyltetrazolium chloride (TTC) staining. There was no difference in the area at risk between the TG and NTG groups. However, infarct size, expressed by a fraction of area at risk was significantly lower, p<0.01, in the TG group (31±3.4%) compared to the NTG animals (52±3.6%). The frequency of apoptosis (TUNEL) in the area at risk in TG mice was also significant reduced, p<0.05, compared to NTG mice (0.53±0.2 vs. 1.60±0.5 myocytes/field). Thus, the TG α1A‐AR mice exhibited marked protection against the development of infarction and apoptosis, indicating that this model should be uniquely useful for understanding the role of α1A‐AR in IP.
What problem does this paper attempt to address?